Use of IGFBP7 for treating malaria
AssigneeAgency for Science, Technology and Research
InventorsWenn-Chyau Lee, Laurent Renia
Life of this patent
Estimating the term…
Abstract
The invention relates to a composition comprising insulin growth factor binding protein 7 (IGFBP7) for treating malaria or reducing the phenomenon of IRB C-endothelial cytoadherence. The composition can further comprise Von Willebrand Factor (VWF) and/or thrombospondin-1 (TSP-1). The composition can also be used as an adjunct therapeutic agent alongside other anti-malarial drugs.
Claims14
A composition comprising (i) insulin growth factor binding protein 7 (IGFBP7) and (ii) a Von Willebrand Factor (VWF), and/or a thrombospondin-1 (TSP-1), and/or one or more other anti-malarial drugs.
A method of treating an individual afflicted with malaria comprising administering to the individual an effective amount of insulin growth factor binding protein 7 (IGFBP7).
Dependencies are inferred from the claim text.